薬物および遺伝子送達デバイスの世界市場規模及び予測:遺伝子送達別(経口、吸入、経皮、注射、眼、鼻、局所)、遺伝子送達ベクター別(ウイルス性、非ウイルス性)、遺伝子送達別(その場、体外)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Gene Delivery Type (In situ, Ex vivo), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market snapshot
Chapter 3 Drug and Gene Delivery Systems Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Drug and Gene Delivery Systems – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Drug Delivery Systems Market: Route of Administration Estimates & Trend Analysis
4.1 Drug delivery systems market: Route of Administration Movement Analysis
4.2 Oral
4.2.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.3 Inhalation
4.3.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.4 Transdermal
4.4.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.5 Injectable
4.5.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.6 Ocular
4.6.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.7 Nasal
4.7.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
4.8 Topical
4.8.1 Market Estimates and Forecast, 2014 – 2025 (USD Billion)
Chapter 5 Gene Delivery Systems: Vector Estimates & Trend Analysis
5.1 Gene Delivery Systems Market: Vector Movement Analysis
5.2 Viral Vectors
5.2.1 Market Estimates and Forecast, 2014 – 2025 (USD Million)
5.3 Non-viral Vectors
5.3.1 Market Estimates and Forecast, 2014 – 2025 (USD Million)
Chapter 6 Gene Delivery Systems: Method Estimates & Trend Analysis
6.1 Gene delivery Systems Market: Method Movement Analysis
6.2 Ex vivo
6.3.1 Market Estimates and Forecast, 2014 – 2025 (USD Million)
6.4 In situ
6.4.1 Market Estimates and Forecast, 2014 – 2025 (USD Million)
Chapter 7 Drug and Gene Delivery Systems: Regional Estimates & Trend Analysis, by Route of Administration, Vector and Method
7.1 Drug and gene delivery systems market share by region, 2014 & 2025
7.2 North America
7.2.1 U.S.
7.2.1.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.2.1.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.2.1.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.2.2 Canada
7.2.2.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.2.2.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.2.2.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.3 Europe
7.3.1 U.K.
7.3.1.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.3.1.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.3.1.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.3.2 Germany
7.3.2.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.3.2.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.3.2.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.4 Asia Pacific
7.4.1 Japan
7.4.1.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.4.1.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.4.1.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.4.2 China
7.4.2.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.4.2.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.4.2.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.5 Latin America
7.5.1 Brazil
7.5.1.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.5.1.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.5.1.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.5.2 Mexico
7.5.2.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.5.2.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.5.2.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
7.5.2.4 Market estimates and forecasts, by method 2014 – 2025
7.6 Middle East and Africa (MEA)
7.6.1 South Africa
7.6.1.1 Market estimates and forecasts, by route of administration, 2014 – 2025 (USD Billion)
7.6.1.2 Market estimates and forecasts, by vector 2014 – 2025, USD Million
7.6.1.3 Market estimates and forecasts, by method 2014 – 2025, USD Million
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Pfizer, Inc.
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 F. Hoffmann-La Roche Ltd.
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Johnson and Johnson
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Novartis AG
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 Bayer AG
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 Becton, Dickinson and Company
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Uniqure N.V
8.3.7.1 Company Overview
8.3.7.2 Financial Performance
8.3.7.3 Product Benchmarking
8.3.7.4 Strategic Initiatives
8.3.8 SiBiono GeneTech Co
8.3.8.1 Company Overview
8.3.8.2 Financial Performance
8.3.8.3 Product Benchmarking
8.3.8.4 Strategic Initiatives
8.3.9 Shanghai Sunway Biotech Co., Ltd
8.3.9.1 Company Overview
8.3.9.2 Product Benchmarking
8.3.9.3 Strategic Initiatives
8.3.10 Human Stem Cells Institute
8.3.10.1 Company Overview
8.3.10.2 Financial Performance
8.3.10.3 Product Benchmarking
8.3.10.4 Strategic Initiatives


【レポート販売概要】

■ タイトル:薬物および遺伝子送達デバイスの世界市場規模及び予測:遺伝子送達別(経口、吸入、経皮、注射、眼、鼻、局所)、遺伝子送達ベクター別(ウイルス性、非ウイルス性)、遺伝子送達別(その場、体外)、セグメント予測、2014-2025
■ 英文:Drug And Gene Delivery Devices Market Analysis By Drug Delivery Type (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Gene Delivery Vector (Viral, Non-viral), By Gene Delivery Type (In situ, Ex vivo), And Segment Forecasts, 2014-2025
■ 発行日:2016年12月8日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707266
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。